Solhan Health Services Vocational School, Bingol University, Bingol 12000, Turkiye ...
Each cell in our body experiences up to tens of thousands of DNA-damaging events per day, primarily from routine cellular maintenance or exposure to toxins in our environment. Despite the high ...
After hours: December 5 at 5:22:47 PM EST Loading Chart for KZR ...
Often patients with these cancers are prescribed chemotherapeutics, but sometimes this strategy stops working and scientists don't really know why. "For these patients, there aren't any good ...
There may thus be a therapeutic rationale for continuing cisplatin therapy (in addition to second-line chemotherapeutics) despite the presence of cisplatin-resistant disease, in an effort to ...
In the United States, noroviruses are the single most common cause of acute gastroenteritis in adults that results in a visit to the hospital emergency department, and they are second only to ...
We are excited to expand our pipeline to include this portfolio of potent nucleoside chemotherapeutics with significant therapeutic potential against a variety of cancers," said Eckard Weber ...
Expert Rev Gastroenterol Hepatol. 2012;6(5):591-601. Limited research has been developed on the molecular basis of EGE and its pathophysiology is poorly known, with most of the available ...
This study utilizes an elegant approach to examine valence encoding of the mesolimbic dopamine system. The findings are valuable, demonstrating differential responses of dopamine to the same taste ...
However, it is important to know that supplements and herbal remedies can not treat, cure, or prevent disease. Forgoing traditional chemotherapeutics and relying on alternative therapies can worsen ...
When compared with other orally administered chemotherapeutics, only nalidixic acid is active against the majority of klebsiella-aerobacter as well as proteus strains, which are relatively common ...
Gallbladder cancer is the latest form of cancer to be on the rise among people under 50, similar to bowel, breast, and lung ...